litlas
Log inCreate account

Kjell Öberg

Active 1981–2021

162
Papers
37,554
Citations
105
h-index
162
i10-index

Citations

Citations per year for Kjell Öberg1973: 1 citations1983: 3 citations1984: 3 citations1985: 1 citations1986: 10 citations1987: 11 citations1988: 14 citations1989: 39 citations1990: 32 citations1991: 40 citations1992: 46 citations1993: 55 citations1994: 51 citations1995: 55 citations1996: 55 citations1997: 58 citations1998: 93 citations1999: 103 citations2000: 130 citations2001: 130 citations2002: 106 citations2003: 152 citations2004: 219 citations2005: 186 citations2006: 206 citations2007: 178 citations2008: 182 citations2009: 186 citations2010: 252 citations2011: 282 citations2012: 261 citations2013: 228 citations2014: 233 citations2015: 241 citations2016: 224 citations2017: 297 citations2018: 315 citations2019: 908 citations2020: 975 citations2021: 845 citations2022: 576 citations2023: 456 citations2024: 708 citations2025: 279 citations2026: 7 citations1974–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,903 citing papers, 22.3% of this breakdownItaly: 755 citing papers, 8.8% of this breakdownGermany: 714 citing papers, 8.4% of this breakdownUnited Kingdom: 567 citing papers, 6.6% of this breakdownFrance: 510 citing papers, 6% of this breakdownNetherlands: 448 citing papers, 5.2% of this breakdownSweden: 435 citing papers, 5.1% of this breakdownChina: 374 citing papers, 4.4% of this breakdownSwitzerland: 301 citing papers, 3.5% of this breakdownCanada: 276 citing papers, 3.2% of this breakdownAustralia: 219 citing papers, 2.6% of this breakdownSpain: 204 citing papers, 2.4% of this breakdown
0%22.3%Other 21.5%

Institutions

Fields

  • Medicine87.2%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Neuroscience1.6%
  • Immunology and Microbiology1.1%
  • Health Professions0.3%
  • Computer Science0.2%
  • Other1.4%

Topics

  • Neuroendocrine Tumor Research Advances21.1%
  • Lung Cancer Research Studies12.5%
  • Neuroblastoma Research and Treatments8.7%
  • Pancreatic and Hepatic Oncology Research4.7%
  • Radiopharmaceutical Chemistry and Applications3.5%
  • Thyroid Cancer Diagnosis and Treatment2.6%
  • Other46.9%

Coauthors

All papers

Open in search
  1. Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

    Authors: Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning - New England Journal of Medicine 2017 cited by 3,178

  2. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Marianne Pavel, Kjell Öberg, M. Falconi, E. P. Krenning, Anders Sundin, Aurel Perren, Alfredo Berruti - Annals of Oncology 2020 cited by 1,146

  3. Everolimus for Advanced Pancreatic Neuroendocrine Tumors

    Authors: James C. Yao, Manisha H. Shah, Tetsuhide Ito, C. Lombard Bohas, Edward M. Wolin, Eric Van Cutsem, Timothy J. Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G.E. de Vries, Paola Tomassetti, Marianne Pavel, Sakina Hoosen, T Haas, Jeremie Lincy, David Lebwohl, Kjell Öberg - New England Journal of Medicine 2011 cited by 2,848

  4. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

    Authors: Marianne Pavel, Dermot O’Toole, Frederico Costa, Jaume Capdevila, Danae C. Gross, Réza Kianmanesh, E. P. Krenning, Ulrich Knigge, Ramón Salazar, Ulrich‐Frank Pape, Kjell Öberg, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 1,036

  5. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial

    Authors: Jonathan Strosberg, Edward M. Wolin, Beth Chasen, Matthew H. Kulke, David Bushnell, Martyn Caplin, Richard P. Baum, Pamela L. Kunz, Timothy J. Hobday, Andrew Hendifar, Kjell Öberg, Maribel Lopera Sierra, Thomas Thevenet, Inés Margalet, Philippe Ruszniewski, Eric P. Krenning, on behalf of the NETTER-1 Study Group - Journal of Clinical Oncology 2018 cited by 389

  6. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

    Authors: Valentina Ambrosini, Jolanta Kunikowska, Eric Baudin, Lisa Bodei, Catherine Bouvier, Jaume Capdevila, Marta Cremonesi, Wouter W. de Herder, Clarisse Dromain, Massimo Falconi, Melpomeni Fani, Stefano Fanti, Rodney J. Hicks, Levent Kabasakal, Gregory Kaltsas, Valerie Lewington, Silvia Minozzi, Michela Cinquini, Kjell Öberg, Wim J.G. Oyen, Dermot O’Toole, Marianne Pavel, Philippe Ruszniewski, Aldo Scarpa, Jonathan Strosberg, Anders Sundin, David Taïeb, Irene Virgolini, Damian Wild, Ken Herrmann, James C. Yao - European Journal of Cancer 2021 cited by 242

  7. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Authors: M. Caplin, Éric Baudin, Piero Ferollà, Pier Luigi Filosso, Mariano Garcı́a-Yuste, Eric Lim, Kjell Öberg, Giuseppe Pelosi, Aurel Perren, Roberta Rossi, William D. Travis, D.K. Bartsch, Jaume Capdevila, Frederico Costa, Jarosław B. Ćwikła, Wouter W. de Herder, Gianfranco Delle Fave, Barbro Eriksson, Massimo Falconi, Diego Ferone, David J. Gross, Ashley Grossman, Tetsuhide Ito, Robert T. Jensen, Gregory Kaltsas, Fahrettin Keleştimur, Réza Kianmanesh, Ulrich Knigge, Beata Kos‐Kudła, Eric P. Krenning, Emmanuel Mitry, M. Nicolson, Juan Manuel O’Connor, Dermot O’Toole, Ulrich-Frank Pape, Marianne Pavel, John Ramage, Éric Raymond, Guido Rindi, Andrea Rockall, Philippe Ruszniewski, Ramón Salazar, Aldo Scarpa, Eva Sedláčková, Anders Sundin, Christos Toumpanakis, Marie‐Pierre Vullierme, Wolfgang Weber, Bertram Wiedenmann, Zeng Zheng-Pei - Annals of Oncology 2015 cited by 699

  8. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    Authors: Marianne Pavel, John D. Hainsworth, Éric Baudin, Marc Peeters, Dieter Hörsch, Robert Winkler, Judith Klimovsky, David Lebwohl, Valentine Jehl, Edward M. Wolin, Kjell Öberg, Eric Van Cutsem, James C. Yao - The Lancet 2011 cited by 1,052

  9. Gastroenteropancreatic neuroendocrine tumours

    Authors: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 cited by 1,752

  10. Consensus on biomarkers for neuroendocrine tumour disease

    Authors: Kjell Öberg, Irvin M. Modlin, Wouter W. de Herder, Marianne Pavel, David S. Klimstra, Andrea Frilling, David C. Metz, Anthony P. Heaney, Dik J. Kwekkeboom, Jonathan Strosberg, T Meyer, Steven F. Moss, Kay Washington, Edward M. Wolin, Eric Liu, James R. Goldenring - The Lancet Oncology 2015 cited by 280

  11. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

    Authors: Marianne Pavel, Éric Baudin, Anne Couvelard, Eric P. Krenning, Kjell Öberg, Thomas Steinmüller, Martin Anlauf, Bertram Wiedenmann, Ramón Salazar - Neuroendocrinology 2012 cited by 870

  12. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum

    Authors: Bruno Niederle, Ulrich F. Pape, Frederico Costa, Danae C. Gross, Fahrettin Keleştimur, Ulrich Knigge, Kjell Öberg, M. Pavel, Aurel Perren, Christos Toumpanakis, Juan Manuel O’Connor, Dermot O’Toole, E. P. Krenning, N. Reed, Réza Kianmanesh, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 473

  13. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

    Authors: Aurel Perren, Anne Couvelard, Jean‐Yves Scoazec, Frederico Costa, Ivan Borbath, Gianfranco Delle Fave, Vera Gorbounova, David J. Gross, Ashley Grossman, Robert T. Jensen, Matthew H. Kulke, Kjell Öberg, Guido Rindi, Halfdan Sørbye, Staffan Welin, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 cited by 248

  14. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

    Authors: Matthew H. Kulke, Dieter Hörsch, Martyn Caplin, Lowell Anthony, Emily K. Bergsland, Kjell Öberg, Staffan Welin, Richard R.P. Warner, Catherine Lombard‐Bohas, Pamela L. Kunz, Enrique Grande, Juan W. Valle, Douglas Fleming, Pablo Lapuerta, Phillip Banks, Shanna Jackson, Brian Zambrowicz, Arthur Sands, Marianne Pavel - Journal of Clinical Oncology 2017 cited by 301

  15. Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study

    Authors: James C. Yao, Marianne Pavel, Catherine Lombard‐Bohas, Eric Van Cutsem, Maurizio Voi, Ulrike Brandt, Wei He, David Chen, Jaume Capdevila, Elisabeth G.E. de Vries, Paola Tomassetti, Timothy J. Hobday, Rodney F. Pommier, Kjell Öberg - Journal of Clinical Oncology 2016 cited by 269

  16. Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome – An International Consensus Statement

    Authors: Bruno Niederle, Andreas Selberherr, Detlef K. Bartsch, Maria Luisa Brandi, Gerard M. Doherty, Massimo Falconi, Pierre Goudet, Þorvarður R. Hálfdánarson, Tetsuhide Ito, Robert T. Jensen, Alberto Larghi, Lingaku Lee, Kjell Öberg, Marianne Pavel, Aurel Perren, Samira M. Sadowski, Flavio Tonelli, Frédéric Triponez, Gerlof D. Valk, Dermot O’Toole, David Scott‐Coombes, Rajesh V. Thakker, Geoffrey B. Thompson, Giorgio Treglia, Bertram Wiedenmann - Neuroendocrinology 2020 cited by 129

  17. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

    Authors: on behalf of the NETTER-1 study group, Jonathan Strosberg, Pamela L. Kunz, Andrew Hendifar, James C. Yao, David Bushnell, Matthew H. Kulke, Richard P. Baum, Martyn Caplin, Philippe Ruszniewski, Ebrahim S. Delpassand, Timothy J. Hobday, Chris Verslype, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaume Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Giovanni Paganelli, Stefano Severi, Michael Morse, David C. Metz, C. Ansquer, F. Courbon, Adil Al‐Nahhas, Eric Baudin, Francesco Giammarile, David Taïeb, Erik Mittra, Edward M. Wolin, Thomas M. O’Dorisio, Rachida Lebtahi, Christophe M. Deroose, Chiara Maria Grana, Lisa Bodei, Kjell Öberg, Berna Polack, Beilei He, Maurizio Mariani, Germo Gericke, Paola Santoro, Jack L. Erion, Laura Ravasi, Eric P. Krenning - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 127

  18. ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)

    Authors: Ulrich‐Frank Pape, Bruno Niederle, Frederico Costa, Danae C. Gross, Fahrettin Keleştimur, Réza Kianmanesh, Ulrich Knigge, Kjell Öberg, M. Pavel, Aurel Perren, Christos Toumpanakis, Juan Manuel O’Connor, E. P. Krenning, Nicholas S. Reed, Dermot O’Toole, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 cited by 295

  19. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

    Authors: Kjell Öberg, Anne Couvelard, Gianfranco Delle Fave, David J. Gross, A. Grossman, Robert T. Jensen, Ulrich‐Frank Pape, Aurel Perren, Guido Rindi, Philippe Ruszniewski, Jean‐Yves Scoazec, Staffan Welin, Bertram Wiedenmann, Diego Ferone, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 cited by 173

  20. Long‐Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center

    Authors: Olov Norlén, Peter Stålberg, Kjell Öberg, John Eriksson, Jakob Hedberg, Ola Hessman, Eva Tiensuu Janson, Per Hellman, Göran Åkerström - World Journal of Surgery 2011 cited by 256

  21. Neuroendocrine Neoplasms of the Small Bowel and Pancreas

    Authors: Ashley Kieran Clift, Mark Kidd, Lisa Bodei, Christos Toumpanakis, Richard P. Baum, Kjell Öberg, Irvin M. Modlin, Andrea Frilling - Neuroendocrinology 2019 cited by 121

  22. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future

    Authors: Kjell Öberg, Steven W. J. Lamberts - Endocrine Related Cancer 2016 cited by 100

  23. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

    Authors: Anna Malczewska, Beata Kos‐Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Öberg, Irvin M. Modlin - Advances in Medical Sciences 2019 cited by 58

  24. Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor Angiogenesis

    Authors: Zofia von Marschall, A Scholz, Thorsten Cramer, Günter Schäfer, Michael Schirner, Kjell Öberg, Bertram Wiedenmann, Michael Höcker, Stefan Rosewicz - JNCI Journal of the National Cancer Institute 2003 cited by 325